Free Trial

Eledon Pharmaceuticals (ELDN) Earnings Date, Estimates & Call Transcripts

$2.55
+0.04 (+1.59%)
(As of 10/3/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Nov. 14Estimated
Actual EPS
(Aug. 19)
-$0.32 Missed By -$0.01
Consensus EPS
(Aug. 19)
-$0.31
Skip Charts & View Estimated and Actual Earnings Data

ELDN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ELDN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Eledon Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.35)($0.33)($0.34)
Q2 20243($0.36)($0.30)($0.33)
Q3 20243($0.37)($0.20)($0.29)
Q4 20243($0.38)($0.16)($0.28)
FY 202411($1.46)($0.99)($1.24)

ELDN Earnings Date and Information

Eledon Pharmaceuticals last issued its earnings data on August 19th, 2024. The reported ($0.32) earnings per share for the quarter, missing the consensus estimate of ($0.31) by $0.01. Eledon Pharmaceuticals has generated ($1.38) earnings per share over the last year (($1.38) diluted earnings per share). Earnings for Eledon Pharmaceuticals are expected to grow in the coming year, from ($1.52) to ($0.73) per share. Eledon Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off prior year's report dates.

Eledon Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/14/2024
(Estimated)
------- 
8/19/2024Q2 2024($0.31)($0.32)($0.01)$0.42--
5/9/2024Q1 2024($0.37)($0.34)+$0.03($0.34)--  
3/28/2024Q4 2023($0.38)($0.29)+$0.09($0.29)--  
11/9/2023Q3 2023($0.41)($0.35)+$0.06($0.35)--  
8/10/2023Q2 2023($0.47)($0.40)+$0.07($0.40)--  
5/11/2023Q1 2023($0.71)($0.75)($0.04)($0.75)--  
3/30/2023Q4 2022($0.70)($0.68)+$0.02$2.73--
11/14/2022Q3 2022($0.68)($0.73)($0.05)($0.73)--  
8/11/2022Q2 2022($0.72)($0.65)+$0.07($0.65)--  
5/12/2022Q1 2022($0.67)($0.69)($0.02)($0.69)--  
3/24/2022Q4 2021($0.83)($0.59)+$0.24($0.59)--      
11/11/2021Q3 2021($0.67)($0.66)+$0.01($0.66)--      
8/12/2021Q2 2021($0.58)($0.50)+$0.08($0.50)--      
5/13/2021Q1 2021($0.37)($0.57)($0.20)($0.57)--    
11/16/2020Q3 2020($1.64)($3.91)($2.27)($2.31)--
8/14/2020Q2 2020-($0.15)($0.15)($2.70)--
5/15/2020Q1 2020-($0.4694)($0.4694)($8.45)--
3/17/2020Q4 2019($0.23)($0.18)+$0.05($0.72)--
11/13/2019Q3 2019-($0.22)($0.22)($3.96)--

Eledon Pharmaceuticals Earnings - Frequently Asked Questions

When is Eledon Pharmaceuticals's earnings date?

Eledon Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates. Learn more on ELDN's earnings history.

Did Eledon Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Eledon Pharmaceuticals (NASDAQ:ELDN) missed the analysts' consensus estimate of ($0.31) by $0.01 with a reported earnings per share (EPS) of ($0.32). Learn more on analysts' earnings estimate vs. ELDN's actual earnings.

How much profit does Eledon Pharmaceuticals generate each year?

Eledon Pharmaceuticals (NASDAQ:ELDN) has a recorded net income of -$116.54 million. ELDN has generated -$1.38 earnings per share over the last four quarters.

What is Eledon Pharmaceuticals's EPS forecast for next year?

Eledon Pharmaceuticals's earnings are expected to grow from ($1.52) per share to ($0.73) per share in the next year.


More Earnings Resources from MarketBeat


This page (NASDAQ:ELDN) was last updated on 10/3/2024 by MarketBeat.com Staff
From Our Partners